Market research
002412.SHE Hunan Hansen Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 20.66
- Analyst target
- Not available
- Dividend yield
- 3.1%
- Beta
- 0.4
Community
Investor discussion
1 comment
Sign in to join the 002412.SHE discussion.
5 years, 5 months ago
Hunan Hansen Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Hunan Hansen Pharmaceutical Co., Ltd's total revenue rose by 4.2% to $210M since the same quarter in the previous year.
Its net income has increased by 0.4% to $32M since the same quarter in the previous year.
Finally, its free cash flow grew by 10.1% to $69M since the same quarter in the previous year.
Based on the above factors, Hunan Hansen Pharmaceutical Co., Ltd gets an overall score of 4/5.